Cell-Free DNA Methylation as a Potential Biomarker in Brain Disorders
Year: 2022
Type: article
Abstract: EpigenomicsVol. 14, No. 7 CommentaryCell-free DNA methylation as a potential biomarker in brain disordersYulin Jin, Emily G Allen & Peng JinYulin JinDepartment of Human Genetics, School of Medicine, Emory University, Atlanta, GA 30322, USA, Emily G AllenDepartment of Human Genetics, School of Medicine, Emory University, Atlanta, GA 30322, USA & Peng Jin *Author for correspondence: Tel.: +1 404 727 3729; E-mail Address: [email protected]://orcid.org/0000-0001-6137-6659Department of Human Genetics, School of Medicine, Emory University, Atlanta, GA 30322, USAPublished Online:17 Jan 2022https://doi.org/10.2217/epi-2021-0416AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleKeywords: brain disorderscell-free DNAdiagnostic toolDNA methylationPapers of special note have been highlighted as: • of interest; •• of considerable interestReferences1. Siuly S, Zhang Y. Medical big data: neurological diseases diagnosis through medical data analysis. Data Sci. Eng. 1(2), 54–64 (2016).Crossref, Google Scholar2. Sheinerman KS, Umansky SR. Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologies. Front. Cell. Neurosci. 7, 150 (2013).Crossref, Medline, CAS, Google Scholar3. Lo YD, Han DS, Jiang P, Chiu RW. Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies. Science 372(6538), eaaw3616 (2021). •• The most recent and informative overview of cell-free DNA-based molecular studies in disease diagnosis.Crossref, Medline, CAS, Google Scholar4. Feng H, Jin P, Wu H. Disease prediction by cell-free DNA methylation. Brief. Bioinformatics 20(2), 585–597 (2019).Crossref, Medline, CAS, Google Scholar5. Elshimali YI, Khaddour H, Sarkissyan M, Wu Y, Vadgama JV. The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients. Int. J. Mol. Sci. 14(9), 18925–18958 (2013).Crossref, Medline, CAS, Google Scholar6. Sun K, Jiang P, Chan KA et al. Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments. Proc. Natl Acad. Sci. USA 112(40), E5503–E5512 (2015). •• This paper describes the first comprehensive tissue-of-origin studies using cell-free DNA methylome from various disease conditions.Crossref, Medline, CAS, Google Scholar7. Moss J, Magenheim J, Neiman D et al. Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease. Nat. Commun. 9(1), 1–12 (2018). •• The authors report a method to accurately identify cell type-specific cell-free DNA in healthy and pathological conditions.Crossref, Medline, CAS, Google Scholar8. Shen SY, Singhania R, Fehringer G et al. Sensitive tumour detection and classification using plasma cell-free DNA methylomes. Nature 563(7732), 579–583 (2018).Crossref, Medline, CAS, Google Scholar9. Liu M, Oxnard G, Klein E et al. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Ann. Oncol. 31(6), 745–759 (2020).Crossref, Medline, CAS, Google Scholar10. Lehmann-Werman R, Neiman D, Zemmour H et al. Identification of tissue-specific cell death using methylation patterns of circulating DNA. Proc. Natl Acad. Sci. USA 113(13), E1826–E1834 (2016).Crossref, Medline, CAS, Google Scholar11. Nassiri F, Chakravarthy A, Feng S et al. Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes. Nat. Med. 26(7), 1044–1047 (2020). •• Cell-free DNA methylation signatures can distinguish different primary brain tumors.Crossref, Medline, CAS, Google Scholar12. Noushmehr H, Sabedot T, Malta T et al. Detection of glioma and prognostic subtypes by non-invasive circulating cell-free DNA methylation markers. bioRxiv. doi:org/10.1101/601245 (2019) (Epub ahead of print). •• Glioma-specific cfDNA methylation features were identified.Google Scholar13. Ghodsi M, Shahmohammadi M, Modarressi MH, Karami F. Investigation of promoter methylation of MCPH1 gene in circulating cell-free DNA of brain tumor patients. Exp. Brain Res. 238(9), 1903–1909 (2020). • Promoter methylation of the MCPH1 gene in cell-free DNA could be a potential biomarker for brain tumor detection.Crossref, Medline, CAS, Google Scholar14. Liggett T, Melnikov A, Tilwalli S et al. Methylation patterns of cell-free plasma DNA in relapsing–remitting multiple sclerosis. J. Neurol. Sci. 290(1–2), 16–21 (2010).Crossref, Medline, CAS, Google Scholar15. Olsen JA, Kenna LA, Tipon RC, Spelios MG, Stecker MM, Akirav EM. A minimally-invasive blood-derived biomarker of oligodendrocyte cell-loss in multiple sclerosis. EBioMedicine 10, 227–235 (2016).Crossref, Medline, Google Scholar16. Dunaeva M, Derksen M, Pruijn GJ. LINE-1 hypermethylation in serum cell-free DNA of relapsing-remitting multiple sclerosis patients. Mol. Neurobiol. 55(6), 4681–4688 (2018).Crossref, Medline, CAS, Google Scholar17. Mendioroz M, Martínez-Merino L, Blanco-Luquin I, Urdánoz A, Roldán M, Jericó I. Liquid biopsy: a new source of candidate biomarkers in amyotrophic lateral sclerosis. Ann. Clin. Transl. Neurol. 5(6), 763–768 (2018).Crossref, Medline, CAS, Google Scholar18. Caggiano C, Celona B, Garton F et al. Estimating the rate of cell type degeneration from epigenetic sequencing of cell-free DNA. bioRxiv doi:org/10.1101/2020.01.15.907022 (2020) (Epub ahead of printGoogle Scholar19. Pai MC, Kuo YM, Wang IF, Chiang PM, Tsai KJ. The role of methylated circulating nucleic acids as a potential biomarker in Alzheimer's disease. Mol. Neurobiol. 56(4), 2440–2449 (2019). •• This paper details the first cell-free DNA methylation study in Alzheimer's disease.Crossref, Medline, CAS, Google Scholar20. Jr Diaz LA, Bardelli A. Liquid biopsies: genotyping circulating tumor DNA. J. Clin. Oncol. 32(6), 579–586 (2014).Crossref, Medline, Google Scholar21. Pulvers JN, Journiac N, Arai Y, Nardelli J. MCPH1: a window into brain development and evolution. Front. Cell. Neurosci. 9, 92 (2015).Crossref, Medline, Google Scholar22. Karami F, Javan F, Mehrazin M, Mehdipour P. Key role of promoter methylation and inactivation of MCPH1 gene in brain tumors. J. Neurol. Res. 4(5–6), 132–137 (2015).Crossref, Google Scholar23. Tremolizzo L, Messina P, Conti E et al. Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset. Amyotroph. Lateral Scler. Frontotemporal Degener. 15(1–2), 98–105 (2014).Crossref, Medline, CAS, Google Scholar24. Hamzeiy H, Savaş D, Tunca C et al. Elevated global DNA methylation is not exclusive to amyotrophic lateral sclerosis and is also observed in spinocerebellar ataxia types 1 and 2. Neurodegener. Dis. 18(1), 38–48 (2018).Crossref, Medline, CAS, Google Scholar25. Di Francesco A, Arosio B, Falconi A et al. Global changes in DNA methylation in Alzheimer's disease peripheral blood mononuclear cells. Brain Behav. Immun. 45, 139–144 (2015).Crossref, Medline, Google Scholar26. D'addario C, Candia SB, Arosio B et al. Transcriptional and epigenetic phenomena in peripheral blood cells of monozygotic twins discordant for Alzheimer's disease, a case report. J. Neurol. Sci. 372, 211–216 (2017).Crossref, Medline, Google Scholar27. Chatterton Z, Mendelev N, Chen S etal. Brain-derived circulating cell-free DNA defines the brain region and cell-specific origins associated with neuronal atrophy. bioRxiv doi:org/10.1101/538827 (2019) (Epub ahead of print).Google Scholar28. Siejka-Zielińska P, Cheng J, Jackson F et al. Cell-free DNA TAPS provides multimodal information for early cancer detection. Sci. Adv. 7(36), eabh0534 (2021).Crossref, Medline, CAS, Google Scholar29. Stephanie C, Jiang P, Peng W et al. Single-molecule sequencing reveals a large population of long cell-free DNA molecules in maternal plasma. Proc. Natl Acad. Sci. USA 118(50), e2114937118 (2021). • The size of cell-free DNA molecules from different tissue sources was observed to be different.Crossref, Medline, Google ScholarFiguresReferencesRelatedDetails Vol. 14, No. 7 Follow us on social media for the latest updates Metrics Downloaded 202 times History Received 25 October 2021 Accepted 7 January 2022 Published online 17 January 2022 Published in print April 2022 Information© 2022 Future Medicine LtdKeywordsbrain disorderscell-free DNAdiagnostic toolDNA methylationFinancial & competing interests disclosureThe authors are funded by the National Institute of Neurological Disorders and Stroke (grant no.: NS111602) and Woodruff Health Sciences Center Synergy Award. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.No writing assistance was utilized in the production of this manuscript.PDF download
Source: Epigenomics
Authors: Yulin Jin, Emily G Allen, Peng Jin
Institution: Emory University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W4205778622